Tuberc Respir Dis.  2012 Jul;73(1):48-55. 10.4046/trd.2012.73.1.48.

The National Status of Tuberculosis Using Nationwide Medical Records Survey of Patients with Tuberculosis in Korea

• Park YS
• Hong SJ
• Boo YK
• Hwang ES
• Kim HJ
• Cho SH
• Na KI
• Cho EH
• Shin SS

• KMID: 2050674
• DOI: http://doi.org/10.4046/trd.2012.73.1.48

Abstract

BACKGROUND
The epidemiology of tuberculosis (TB) has been assessed based on the data of the analysis of TB patients notified to the surveillance system in Korea. However, the national status of TB is not validated through this surveillance system. The objective is to determine the epidemiology of TB and to understand the accurate status of TB patients treated in private institutions.
METHODS
Medical records of 53,579 patients who had been diagnosed with TB in 2008 were analyzed.
RESULTS
Among 53,579 patients, the number of sputum smear positive cases was 15,639(29.2%) and the number of new cases was 39,191 (73.1%). The drug resistance rate of new cases was 5.3%, while the rate stood at 13.3% for TB patients with treatment history. The number of multi-drug resistant TB (MDR-TB) patients was 2,472 (4.6%), which consists of 2.9% of new cases and 9.3% of TB patients with prior treatment history. The number of extensively drug-resistant TB patients was 749 (1.4%), consisting of 1.1% of new cases and 2.2% of TB patients with prior treatment history. In terms of treatment outcomes, 66.4% of all TB patients, 70.5% of new cases, 64.4% of relapse cases, and 46.8% of MDR-TB cases were cured or completed. It was inferred that in 2008, the total number of TB patients reached 70,767, 145.6 per 100,000 people (95% confidence interval, 145.5~145.7).
CONCLUSION
We conclude that the medical records review of the Health Insurance Review and Assessment Service (HIRA) data can be very effective in promoting the understanding of the current status of TB in private institutions.

Keyword

Tuberculosis; Disease Notification; Epidemiology; Tuberculosis, Multidrug-Resistant; Medical Records; Data Collection

MeSH Terms

Data Collection
Disease Notification
Drug Resistance
Humans
Insurance, Health
Korea
Medical Records
Recurrence
Sputum
Tuberculosis
Tuberculosis, Multidrug-Resistant

Figure

• 

  Figure 1 Rate of resistance to anti TB drugs in MDR-TB and XDR-TB patient. TB: tuberculosis; MDR-TB: multi-drug resistant TB; XDR-TB: extensively drug-resistant TB.

Reference

1. Kim YS, Park KH, Yoo HS, Kwon JW, Shin E. Reporting of national notifiable infectious diseases (NNIDs) and related characteristics. Korean J Epidemiol. 2007. 29:200–210.

2. Korea Centers for Disease Control and Prevention. Annual report on the notified tuberculosis patients in Korea 2010. 2011. Cheongwon: Korea Centers for Disease Control and Prevention.

3. Korea Centers for Disease Control and Prevention. Guidelines for national tuberculosis control, 2011. 2011. Cheongwon: Korea Centers for Disease Control and Prevention.

4. World Health Organization. Treatment of tuberculosis guidelines. 2009. 4th ed. Geneva: World Health Organization.

5. Ministry of Health and Welfare, Korean Institute of Tuberculosis, Korean National Tuberculosis Association. Report on the 7th tuberculosis prevalence survey in Korea. 1996. Seoul: Korean Institute of Tuberculosis.

6. Bai GH, Park YK, Choi YW, Bai JI, Kim HJ, Chang CL, et al. Trend of anti-tuberculosis drug resistance in Korea, 1994-2004. Int J Tuberc Lung Dis. 2007. 11:571–576.